CSF Liquid Biopsy May Improve Diagnosis of Leptomeningeal Disease
A study reports that CSF liquid biopsy measuring variant allele frequency may improve leptomeningeal disease diagnosis, especially when MRI and cytology are inconclusive.
A study reports that CSF liquid biopsy measuring variant allele frequency may improve leptomeningeal disease diagnosis, especially when MRI and cytology are inconclusive.
As autoimmune and allergy test volumes rise, labs are prioritizing workflow standardization and structured testing pathways to ensure reliable results, according to Santhosh Nair, president of immunodiagnostics at Thermo Fisher Scientific.
Foundation Medicine will acquire SAGA Diagnostics’ Pathlight MRD platform, expanding its cancer monitoring portfolio. The $595 million deal is expected to close by Q3 2026, with integration supporting treatment selection and recurrence monitoring.
The regional laboratory will use the Concentriq platform to expand diagnostic services and streamline clinical workflows across its network.
Optical genome mapping detected clinically significant genetic variants missed by standard tests in nearly 20% of acute leukemia cases, according to a 200-patient study.